Dr. Parks' focus is on clinical care of patients with cardiomyopathy and heart failure and management of patients who have or need a heart transplantation.
Dr. Parks is a graduate of Kansas City University of Medicine and Biosciences and completed her residency and fellowship through Robert Wood Johnson Medical School. She completed subspecialty training in advanced heart failure and cardiac transplantation at Massachusetts General Hospital where she currently practices with a focus on clinical care. She is an instructor in medicine at Harvard Medical School and is actively involved in teaching residents, fellows and medical students. She is the Associate Director of the Resynchronization and Advanced Cardiac Therapeutics Program at the MGH, which is an innovate, multidisciplinary program designed to optimize the care of patients with heart failure who have or may need implanted deviced for heart failure.
She has been an active participant in medical organizations, previously serving on the governing council of the American Medical Association. She has received awards in teaching and for her leadership and has lectured nationally and internationally on heart failure and cardiac transplantation. Her interests are focused on clinical care of patients with heart failure and research has focused on the clinical use of novel and established implantable devices in the management of heart failure patients.
Dr. Parks is a clinician innovator dedicated to exploring new models of care to efficiently manage patients and improve outcomes. actively involved with the healthcare transformation lab's ?TeleHeart? virtual visit program, a program in which patients can login to a secure website and enter a ?virtual office? where they meet their provider for a video visit.
ResearchClinical research focus is on investigational devices for heart failure including cardiac resynchronization therapy, remote monitoring of heart failure, implantable monitoring devices via direct and indirect left atrial pressure monitoring and technologies aimed at reducing heart failure hospitalizations and improving morbidity. Current multi center device trials open to enrollment include those using neuromodulation to treat heart failure, stem cell therapy and an implantable pulmonary artery sensor.
See Pub Med link above for access to published research articles.
For two years, Amy DeStefano struggled with increasing heart complications, leaving her needing a heart transplantation. Through one of Mass General’s clinical trials, Amy became the first person in New England to receive a "heart in a box" transplant. The device circulates blood through the donated heart, keeping it beating and giving doctors more time to perform a transplant.
MGH Hotline 1.15.10 It's not often one encounters a touching love story within the four walls of the hospital.
Q&A with Kim Parks, DO, a transplant cardiologist
MGH Hotline 08.06.10 Kimberly Parks, DO, a transplant cardiologist at the Massachusetts General Hospital Heart Center, is one of several physicians featured in "Boston Med."
Kimberly A. Parks, DO, FACC, cardiologist at Massachusetts General Hospital and James Mojica, MD, associate program director of the Harvard Pulmonary Critical Care Medicine Fellowship Training Program discuss the safety of caffeine inhalers
February is American Heart Month, and the spotlight is on heart health. Throughout this month, we will be featuring articles including discussions with physicians in the Massachusetts General Heart Center to learn more about the topics surrounding heart disease, the leading cause of death in the U.S. for both men and women.
Anita Levy, 59, arrived at Massachusetts General Hospital in 2012 with severe heart failure. The mother of four, grandmother of eight and wife of 38 years, was starting to lose hope. After trying a number of therapies without success, her doctors informed her she was a candidate for a new clinical trial.